- China: SFDA, Good Manufacturing Practice for Drugs
- China: SFDA, State Food and Drug Administration, P.R. China
- India: Central Drugs Standard Control Organization, Directorate General of Health Service, Ministry of Health and Family Welfare, Government of India
- India: Good Manufacturing Practices and Requirements of Premises, Plant and Equipment for Pharmaceutical Products (Schedule M)
- EC (European Commission): Enterprise DG Pharmaceuticals
- EMA – European Medicines Agency – Homepage
- EMA: Concept Paper on Storage Conditions during Transport
- EMA: Concept Paper on the Revision of Chapter 6 of the EU GMP Guide Quality Control
- EMA: Documentation Service – Contacts
- EMA: history and description
- EMA: news and events
- EU-GDP-Guideline (Draft 2011)
- EU-GMP-Guidelines
- EU-Pharmacopeia (Ph.Eur.) – online-Version – edqm
- WHO (World Health Organization): Regional Office for Europe
- Bulgaria: Bulgarian Drug Agency
- Czech Republic: State Institute for Drug Control
- Hungary: National Institute of Pharmacy
- Lithuania: State Medicines Control Agency
- Romania: National Medicines Agency
- Austria: Bundesministerium für Gesundheit, Familie und Jugend
- Germany: Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)
- Germany: Paul-Ehrlich-Institut (PEI)
- Germany: Robert Koch Institut
- Germany: Zentrale Gesundheitsbehörde der Länder (ZLG)
- Switzerland: Bundesamt für Gesundheit
- Switzerland: Swissmedic Schweizerisches Heilmittelinstitut(früher: Interkantonale Kontrollstelle für Heilmittel (IKS))
- Denmark: Danish Medicines Agency
- Finland: Medicines Agency – Fimea
- Iceland: Icelandic Medicines Agency (IMA)
- Sweden: Medical Products Agency – Läkemedelsverket
- Greece: Adverse Drug Reactions Section
- Italy: Ministero della Salute
- Malta: Medicines Regulatory Unit
- Belgium: Federal Agency for Medicines and Health Products
- France: Ministère de la santé
- Ireland: Irish Medicines Board
- UK: Medicines and Healthcare products Regulatory Agency (MHRA)
- CFR: Code of Federal Regulations Title 21
- FDA: Counterfeit Medicine
- FDA: Foreign Inspections
- FDA: Glossary of Computer Systems Software Development Terminology
- FDA: Guidance, Compliance and Regulatory Infomation (CDER)
- FDA: Guideline for Drug Master Files
- FDA: Homepage – U.S. Food and Drug Administration
- FDA: Inspection Guides
- FDA: Process Validation
- FDA: Warning letters
- Health Canada: Good Manufacturing Practices
- Health Canada: Guidance Documents
- DIA: Drug Information Association for Europe
- EDQM: European Department for the Quality of Medicines Council of Europe
- Eucomed: European Medical Device Industry Group
- IPEC: The International Pharmaceutical Excipients Council Europe
- ISPE: The International Society for Pharmaceutical Engineering
- MHRA: Medicines and Healthcare products Regulatory Agency (GB)
- PDA: Parenteral Drug Association – Europe
- PIC/S: Pharmaceutical Inspection Co-operation Scheme
- GHTF: Global Harmonization Task Force
- ICH: International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use
- IFPMA: International Federation of Pharmaceutical Manufacturers Associations
- OECD: Organization for Economic Co-Operation and Development
- WSMI: WORLD Self-MEDICATION INDUSTRY
- aaps: American Association of Pharmaceutical Scientists
- APhA: American Pharmaceutical Association
- DIA: Drug Information Association
- ISPE: Headquarters
- NIH: National Institutes of Health
- PDA: Parenteral Drug Associations
- PhRMA: Pharmaceutical Research and Manufacturers of America
- USP: U.S. Pharmacopeial Convention